iPSC-derived NK cells maintain high cytotoxicity and enhance in vivo tumor control in concert with T cells and anti–PD-1 therapy
Work
Year: 2020
Type: article
Abstract: The development of immunotherapeutic monoclonal antibodies targeting checkpoint inhibitory receptors, such as programmed cell death 1 (PD-1), or their ligands, such as PD-L1, has transformed the oncol... more
Source: Science Translational Medicine
Institutions University of Minnesota, Fate Therapeutics (United States), Sanford Consortium for Regenerative Medicine, University of California, San Diego
Cites: 62
Cited by: 188
Related to: 10
FWCI: 11.55
Citation percentile (by year/subfield): 99.99
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: green
Grant IDS R00 HL123638, CA197292